跳至主要内容
临床试验/EUCTR2015-004745-70-NL
EUCTR2015-004745-70-NL进行中(未招募)1 期

Efficacy of intranasal ketamine on acute suicidality, a double blind randomized placebo-controlled trial(Ketamine Trial Amsterdam, KETA) - Ketamine Trial Amsterdam, (KETA)

Academic Medical Center (AMC)0 个研究点目标入组 128 人开始时间: 2018年8月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Acute suicidality
  • A Beck Scale for Suicide Ideation (BSSI)-score of 7 or above
  • Subjects are in the age of 18-70
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 110
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 18

排除标准

  • -Psychosis
  • -A diagnosis of schizophrenia or another psychotic disorder
  • -A history of PCP- or ketamine addiction
  • -Being under influence of GHB
  • -A blood alcohol concentration (BAC)of >0.05%
  • -A clinically significant and unstable cardiovascular, gastro-intestinal, pulmonal, renal, hepatic, endocrine or haematological disorder, a myocardial infarction, miction problems or a complex surgical problem that needs immediate attention
  • -A known hypersensitivity for ketamine
  • -Concomitant use of seligiline
  • -Severe nose congestion or nasal polyps
  • -Pregnancy or giving breastfeeding
  • -Women using unreliable contraception
  • -Being unable to answer the questionnaires
  • -Being unwilling or unable to provide informed consent
  • -Earlier participation in this study

研究者

发起方
Academic Medical Center (AMC)

相似试验

Efficacy of ketamine nose-spray on acute suicidal... | 临床试验